Cargando…
Novel CSF biomarkers in genetic frontotemporal dementia identified by proteomics
OBJECTIVE: To identify novel CSF biomarkers in GRN‐associated frontotemporal dementia (FTD) by proteomics using mass spectrometry (MS). METHODS: Unbiased MS was applied to CSF samples from 19 presymptomatic and 9 symptomatic GRN mutation carriers and 24 noncarriers. Protein abundances were compared...
Autores principales: | van der Ende, Emma L., Meeter, Lieke H., Stingl, Christoph, van Rooij, Jeroen G. J., Stoop, Marcel P., Nijholt, Diana A. T., Sanchez‐Valle, Raquel, Graff, Caroline, Öijerstedt, Linn, Grossman, Murray, McMillan, Corey, Pijnenburg, Yolande A. L., Laforce, Robert, Binetti, Giuliano, Benussi, Luisa, Ghidoni, Roberta, Luider, Theo M., Seelaar, Harro, van Swieten, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469343/ https://www.ncbi.nlm.nih.gov/pubmed/31019994 http://dx.doi.org/10.1002/acn3.745 |
Ejemplares similares
-
Clinical Value of Longitudinal Serum Neurofilament Light Chain in Prodromal Genetic Frontotemporal Dementia
por: Giannini, Lucia A.A., et al.
Publicado: (2023) -
Neurofilament light chain: a biomarker for genetic frontotemporal dementia
por: Meeter, Lieke H., et al.
Publicado: (2016) -
Frontotemporal Dementia: Correlations Between Psychiatric Symptoms and Pathology
por: Scarioni, Marta, et al.
Publicado: (2020) -
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study
por: Bergström, Sofia, et al.
Publicado: (2021) -
Longitudinal Brain Atrophy Rates in Presymptomatic Carriers of Genetic Frontotemporal Dementia
por: Poos, Jackie M., et al.
Publicado: (2022)